Mana Pharma

  • MANA PHARMA TEAM
About Mana Pharma

Committed to health
MANA PHARMA is a Spanish company, specializing in the international distribution and commercialization of pharmaceutical products, APIs, medical devices, and dietary supplements. MANA is MAH Laboratory of medicines for human use and Local Representative in Spain for MAH Labs in EU. Our company excels in executing “turnkey” industrial projects, like construction of pharmaceutical plants and hospitals. Our highly qualified team provides personalized and competitive solutions as your strategic ally in sector.

Read more Show less
Certifications
  • ISO
    ISO
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • ES
  • 2024
    On CPHI since
  • 2
    Certificates
  • 25 - 49
    Employees
Company types
Pharmaceutical company
Primary activities
End-product distributor (Wholesale)
View company profile
Contact info
Show contact info Hide contact info

Products from Mana Pharma (8)

  • Edrophonium bromide

    Product Edrophonium bromide

    Cognitive & Mental Function; Anticude is a medicine that is used as an antidote to curing agents, including synthetic curing agents, including synthetic ones, in prolonged apnoea and in any syndrome involving any syndrome involving atony of the striated or smooth fibre musculature striated or smooth fibre ...
  • Procainamide Hydrochloride

    Product Procainamide Hydrochloride

    Biocoryl is indicated for the treatment of potentially malignant ventricular arrhythmias in adults over 18years of age.This medicinal product is administered parenterally (intramuscularly or intravenously). The intravenous route should be reserved for emergencies.
  • UROKINASES SYNER MEDICA 500.000

    Product UROKINASES SYNER MEDICA 500.000

    Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae - extensive acute proximal deep vein thrombosis - acute massive pulmonary embolism - acute occlusive peripheral arterial disease with limb threatening ischemia
  • ANTICUDE

    Product ANTICUDE

    Anticude is a medicine that is used as an antidote to curing agents, including synthetic curing agents and synthetic ones, in prolonged apnea and in any syndrome involving atony of the striated or smooth fibre musculature. It is also used in the diagnosis and treatment of myasthenia gravis and to aid in th...
  • BIOCORYL 100 MG/ML

    Product BIOCORYL 100 MG/ML

    Biocoryl is indicated for the treatment of potentially malignant ventricular arrhythmias in adults over 18years of age.This medicinal product is administered parenterally (intramuscularly or intravenously). The intravenous route should be reserved for emergencies. 
  • Uroquinasa (UROKINASE) SYNER MEDICA 100.000 U.I. powder for solution for injection/infusion

    Product Uroquinasa (UROKINASE) SYNER MEDICA 100.000 U.I. powder for solution for injection/infusion

    Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
    - extensive acute proximal deep vein thrombosis
    - acute massive pulmonary embolism
    - acute occlusive peripheral arterial disease with limb threatening ischemia
  • Uroquinasa (UROKINASE) SYNER MEDICA 250.000 U.I. powder for solution for injection/infusion

    Product Uroquinasa (UROKINASE) SYNER MEDICA 250.000 U.I. powder for solution for injection/infusion

    Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
    - extensive acute proximal deep vein thrombosis
    - acute massive pulmonary embolism
    - acute occlusive peripheral arterial disease with limb threatening ischemi...
  • Uroquinasa (UROKINASE) SYNER MEDICA 500.000 U.I. powder for solution for injection/infusion

    Product Uroquinasa (UROKINASE) SYNER MEDICA 500.000 U.I. powder for solution for injection/infusion

    Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
    - extensive acute proximal deep vein thrombosis
    - acute massive pulmonary embolism
    - acute occlusive peripheral arterial disease with limb threatening ischemia

Mana Pharma Resources (2)